On-Demand Webinars
Have a question about our webinars? Check out the Webinar FAQ.The Food and Drug Administration (FDA) regulations governing Investigational New Drug (IND) applications contain specific reporting requirements. Similarly, the Common Rule (i.e., the federal policy for the protection of human ...
Need to improve your study startup timelines? Consider adding a Medicare Coverage Analysis (MCA) to your toolkit. By leveraging an MCA when building your clinical trial budget template, you can ...
Join colleagues from the research community for a discussion on the evolution of clinical trials and how oncology research has influenced agility in clinical trial design.
Many research programs are evaluating how to keep research moving forward in the face of critical staff shortages and budget limitations—during the COVID-19 pandemic and beyond. Sites are busier than ...
The COVID-19 pandemic ushered in a myriad of changes for clinical research professionals. One of the most impactful has been the immediate shift to remote processes to accommodate both research ...
The COVID-19 pandemic has proven that research can be done more efficiently. To make these efficiencies sustainable, the sites’ perspective must be considered. Sponsors, CROs, and sites should engage early ...
Gene therapy research is expanding rapidly in the clinical setting, especially in oncology, rare diseases, and infectious diseases—in fact, gene therapy research plays a crucial role in responding to the ...
In this webinar, Shannon Roznoski, Director of Product Management at Advarra-Forte and Michael Buckley, Manager, CRIT Enterprise Innovation at Memorial Sloan Kettering Cancer Center will discuss their experience as members ...
The unprecedented COVID-19 pandemic has quickly changed how we live and work. This extraordinary situation has resulted in a significant impact on IRB-approved protocols and research yet to go through ...
Cannabis and cannabis-derived products are being used with increasing frequency in both recreational and therapeutic settings. With more widespread use of cannabis, how can data from well-designed clinical research trials ...
